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Maintenance of skeletal muscle is essential for health and survival. There are marked
losses of skeletal muscle mass as well as strength and physiological function under
conditions of low mechanical load, such as space flight, as well as ground based models
such as bed rest, immobilization, disuse, and various animal models. Disuse atrophy is
caused by mechanical unloading of muscle and this leads to reduced muscle mass without
fiber attrition. Skeletal muscle stem cells (satellite cells) and myonuclei are integrally
involved in skeletal muscle responses to environmental changes that induce atrophy.
Myonuclear domain size is influenced differently in fast and slow twitch muscle, but also
by different models of muscle wasting, a factor that is not yet understood. Although the
myonuclear domain is 3-dimensional this is rarely considered. Apoptosis as a mechanism
for myonuclear loss with atrophy is controversial, whereas cell death of satellite cells has
not been considered. Molecular signals such as myostatin/SMAD pathway, MAFbx, and
MuRF1 E3 ligases of the ubiquitin proteasome pathway and IGF1-AKT-mTOR pathway
are 3 distinctly different contributors to skeletal muscle protein adaptation to disuse.
Molecular signaling pathways activated in muscle fibers by disuse are rarely considered
within satellite cells themselves despite similar exposure to unloading or low mechanical
load. These molecular pathways interact with each other during atrophy and also when
various interventions are applied that could alleviate atrophy. Re-applying mechanical load
is an obvious method to restore muscle mass, however how nutrient supplementation
(e.g., amino acids) may further enhance recovery (or reduce atrophy despite unloading
or ageing) is currently of great interest. Satellite cells are particularly responsive to
myostatin and to growth factors. Recently, the hibernating squirrel has been identified
as an innovative model to study resistance to atrophy.
Keywords: skeletal muscle atrophy, muscle cell signaling, myostatin, MuRF1, MAFbx, IGF1-AKT-mTOR, unloading,
resistance exercise
INTRODUCTION
Skeletal muscle plays a significant role in quality of life and is
essential for health and survival. It is highly organized at the
micro- and macroscopic level and plays a major role in mobil-
ity of the human body. Skeletal muscle accounts for ∼40% of
body mass, permits precise movements and is highly adaptive.
The characteristic of plasticity allows skeletal muscle to change
and adapt depending on the stimuli placed upon it. Increases in
mechanical load and increasing workload will stimulate muscle
hypertrophy, while removal ofmechanical load will lead tomuscle
atrophy as an appropriate adaptation to hypogravity (Goldberg
et al., 1975).
Skeletal muscle has the uncanny ability to alter its pheno-
type depending on the mechanical load placed upon it. Disuse
is an expansive label for the low mechanical load or mechanical
unloading of muscle; with the most severe example being that
of lack of gravity in spaceflight. The ground-based model, bed
rest, simulates spaceflight. Physiological changes during bed rest
include 6–24% reduction in muscle mass and strength (Narici
and de Boer, 2011) and other disuse associated changes in skeletal
muscle (Brooks et al., 2008).
Morphological changes with atrophy include a decreased
cross-sectional area of muscle fibers, concomitant reduced whole
muscle volume and mass, but no decrease in number of fibers
(Nicks et al., 1989). This is different to age-related muscle fiber
atrophy which is accompanied by a reduction in number of mus-
cle fibers (Lexell et al., 1988). The process of muscle atrophy is
highly regulated and results in reduced protein content, reduced
force production, increased fatigability and decreased insulin sen-
sitivity (Fauteck and Kandarian, 1995; Harrison et al., 2003),
decreased capillary density of both fiber types and disruption of
the 3-dimensional architecture of skeletal muscle (Hikida et al.,
1997). Skeletal muscle also undergoes a shift in contractile capac-
ity of the fibers toward fast glycolytic phenotypes (Fauteck and
Kandarian, 1995; Fitts et al., 2000). For example, the soleus mus-
cle which is predominantly composed of slow twitch fibers is a
postural muscle and highly susceptible to disuse and fiber type
switching (Booth and Baldwin, 1996).
www.frontiersin.org March 2014 | Volume 5 | Article 99 | 1
Brooks and Myburgh Myonuclear response to disuse atrophy
Disease-induced atrophy (cachexia) is seen in disease states
such as cancer, AIDS, renal failure, congestive heart failure,
chronic obstructive pulmonary disease (COPD) and burns. In
addition to disuse atrophy, cachexia involves an intricate cytokine
and inflammatory response inducing signaling cascades and gene
transcription. This review will focus on disuse atrophy and
selected growth factor-related signaling. Human models of dis-
use, such as immobilization and sedentary lifestyle (inactivity)
include decreased mechanical loading. Immobilization can occur
as a result of various injuries, mostly not of skeletal muscle
so the influence on skeletal muscle is considered a side effect.
Immobilization can also be used as a model to investigate disuse
and load reduction on skeletal muscle as a research intervention.
Unilateral lower limb suspension involves suspension of one limb
while the other is used for movement assisted by crutches. This
model resulted in 5–10% reduction in CSA of Quadriceps muscle
after 4 weeks (for more detailed review about ULLS, the reader
is referred to Hackney and Ploutz-Snyder, 2012). Immobilization
(cast or leg brace) in humans can lead to ∼12% decrease in leg
mass (for more detailed review about immobilization, the reader
is referred to Marimuthu et al., 2011).
Skeletal muscle unloading in rodents is best modeled by
hindlimb suspension (HS; Morey-Holton and Globus, 2002),
which also leads to significant skeletal muscle atrophy particu-
larly in postural, slow-twitch muscles, such as the soleus muscle
(Templeton et al., 1984; Fitts et al., 1986; Riley et al., 1987). The
HS model involves the animal being suspended by the tail which
prevents the back legs from bearing any weight whilst the animals
support their weight on the front legs. The front legs do not take
on the entire weight of the animal since some of the loading is
compensated for by the pulley and wire system that allows the ani-
mal to still move freely in the cage. For a recent extensive review
on disuse atrophy and unloading models, the reader is directed
to Baldwin et al. (2013). Of particular interest are the alterations
in MHC and fiber shifting away from slow-oxidative fiber type
toward fast glycolytic fiber type in the soleus muscle with HS
(Templeton et al., 1984; Elder and McComas, 1987; Riley et al.,
1987; Tsika et al., 1987). This observation is consistent regard-
less of the duration of unloading in different studies. Because of
the location of the MHC genes this suggests that the basal gene
expression by the myonuclei is altered. Thus a concept not fre-
quently considered arises: constitutive gene expression is altered
once the adaptive phase is complete. To understand the role of
the myonuclear response to atrophy it is important to investigate
myonuclei as entities in their own right. The fact that a muscle
fiber is multinucleated and large adds to the complexity of the
myonuclear responses. On the other hand the muscle precurser
cells (satellite cells; SCs) are mononuclear and typically quiescent,
hence their response to disuse may not be similar to those of the
myonuclei.
There is a plethora of research which has been carried
out in human subjects with differing methods and timescales
of atrophy-inducing stimulation. Two recent studies from van
Loon’s laboratory demonstrate that after 5 days cast immobi-
lization (Dirks et al., 2014) and 14 days cast immobilization
(Wall et al., 2013) there are significant losses in muscle strength
and size. Five days of immobilization led to 3.5% reduction in
quadriceps CSA and 9% muscle strength (Dirks et al., 2014). In
young males, there was a 8% decrease in muscle cross-sectional
area and a 23% reduction in quadriceps strength after 14 days
immobilization (Wall et al., 2013). In addition, data from the
Kjaer laboratory also report decreases in fiber size (10; 20%)
and strength (13; 20%) after 4 and 14 days, respectively (Suetta
et al., 2012, 2013). The decrease in whole muscle strength is also
reflected in reduced specific force of single muscle fibers (Hvid
et al., 2013). Bed rest studies of longer duration (e.g., 28 days)
consistently show reduced muscle strength and size (Hikida et al.,
1989; LeBlanc et al., 1992; Edgerton et al., 1995; Ferrando et al.,
1996; Bloomfield, 1997; Brooks et al., 2008). In skeletal muscle
from individuals who were 9 years post-spinal cord injury, there
was considerable atrophy compared to controls and 90% of the
fibers were type II fibers (Verdijk et al., 2012).
Skeletal muscle is a key tissue in maintaining functional abil-
ity and contributing to health status. The aim of this review is to
highlight the important and integrative role of SCs and myonu-
clei in skeletal muscle homeostasis with the focus particularly on
atrophy. Understanding the role of myonuclei and SCs both in
load-bearing and a variety of disuse conditions may lead to ther-
apies to combat deleterious alterations in skeletal muscle that are
specifically targeted to these progenitor cells. Since both SCs and
myonuclei respond to environmental changes, the involvement
of SCs in skeletal muscle health as well as for skeletal muscle
therapies should be further investigated.
MYONUCLEI AND MYONUCLEAR DOMAIN
Despite being post-mitotic and unable to divide and repli-
cate, myonuclei remain essential for skeletal muscle homeosta-
sis, maintenance and adaptive responses. Therefore analysis of
myonuclei may shed light on mechanisms responsible for muscle
fiber loss or on responses to interventions to fight physical dis-
ability such as that seen with ageing and disease (Malatesta and
Meola, 2010).
The theory of myonuclear domain suggests that each skeletal
muscle nucleus governs an area of surrounding cytoplasm (Hall
and Ralston, 1989) and produces enough protein to support the
limited area of cytoplasmic and structural proteins within the
local “domain” (Pavlath et al., 1989). Research has consistently
reported that in situations of positive change in fiber size, i.e.,
with muscle growth, hypertrophy or overload, there are increases
in myonuclear number as the fiber increases in size (Allen et al.,
1995; McCall et al., 1998; Roy et al., 1999a; Adams et al., 2002;
Petrella et al., 2006; VanderMeer et al., 2011). However, a some-
what flexible myonuclear domain size is likely especially during
e.g., the early phase of an adaptive response (Kadi et al., 2004),
either increase or decrease in fiber size or change in metabolic
status.
Myonuclear domain size is different between fast and slow
fiber types (Burleigh, 1977). Slow muscle fibers have higher rates
of protein turnover (Booth and Thomason, 1991) and higher
oxidative capacity has been associated with a higher level of pro-
tein synthesis (Roy et al., 1999b). In general, slow fibers have
larger numbers of myonuclei (Edgerton and Roy, 1991) which
leads to a smaller calculated myonuclear domain size (Tseng
et al., 1994; Allen et al., 1995; Hikida et al., 1997; Brooks et al.,
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2009). Fast muscle fibers have lower oxidative capacity, relatively
lower numbers of myonuclei and larger myonuclear domain sizes
(Burleigh, 1977; Tseng et al., 1994). However, it is well known that
fast twitch fiber sub-types have widely varying oxidative capacity
and multiple hybrid isoforms (Kohn et al., 2007). It has also been
reported that there is a positive correlation between myonuclear
number and fiber size in young mice and this relationship is lost
during adulthood (Bruusgaard et al., 2006). More research needs
to be done to unravel the fiber type/oxidative capacity and age and
myonuclear domain relationship.
MYONUCLEAR DOMAIN AND DISUSE ATROPHY
While the myonuclear domain theory is well substantiated for
the increase and incorporation of myonuclei with muscle hyper-
trophy (see above), the response of the myonuclear number and
myonuclear domain size with atrophy is less conclusive. Despite
less being known about the influence of disuse on myonuclei,
the alterations in muscle morphology, biochemistry and physiol-
ogy suggest that the myonuclei are influencing features of change
within the muscle as well as being influenced by these alterations.
Furthermore, atrophy from disuse occurs rapidly and its devel-
opment is not simply the reverse of skeletal muscle hypertrophy.
Myonuclear loss may follow a different timescale, occurring at
a slower pace than the loss in muscle fiber size (VanderMeer
et al., 2011). This may further complicate our understanding of
change vs. no change of myonuclear domain size in response to
an intervention. It is therefore important to distinguish between
the adaptive phase and the new steady state when considering the
muscle response to unloading.
Based on the myonuclear domain theory and the response
to muscle growth, it could perhaps be inferred that with mus-
cle atrophy there would be an accompanying loss of myonuclei
resulting in maintenance of the myonuclear domain size (Siu and
Alway, 2009). This inference relies on acceptance of the myonu-
clear domain theory that hypothesizes that each myonucleus can
control only a certain domain for protein synthesis and gen-
eral “maintenance.” Although this hypothesis was based on solid
observational data, the mechanisms controlling the removal of
nuclei under conditions that cell death (myofiber necrosis) is
absent, is far from understood. Nonetheless, decreased myonu-
clear numbers are noted in muscles undergoing a variety of
atrophy-inducing experimental conditions in humans and ani-
mals such as spinal cord isolation and transection, microgravity,
hind limb suspension and chronic denervation (Darr and Schultz,
1989; Schmalbruch et al., 1991; Allen et al., 1995, 1996, 1997b,
1999; Day et al., 1995; Rodrigues Ade and Schmalbruch, 1995;
Hikida et al., 1997). However, there have also been recent reports
to suggest that atrophy with HS does not lead to loss of myonuclei
(Bruusgaard et al., 2012).
Myonuclei can be removed by a number of different pro-
cesses, mainly apoptosis or autophagy. Apoptosis is a tightly
regulated process of highly coordinated “programmed cell death.”
The process of apoptosis is a vital mechanism to allow nor-
mal development, tissue turnover and immunological function
(Thompson, 1995) and to maintain tissue homeostasis through-
out the lifespan. Apoptosis as a means of cell death is easy to
conceptualize for mononuclear cells or cells with low nuclear
number. However, in a multi-dimensional, multinucleated cell,
how and why are particular nuclei targeted and not adjacent
nuclei? There appears to be a fiber type-specific response of
myonuclear loss, with a greater decrease in myonuclear number
in Type I (Zhong et al., 2005) fibers that respond to unloading
with more severe atrophy. In contrast excess glucocorticoid pro-
duction such as that with cachexia results in fast glycolytic fibers
being more affected (recently reviewed by Schakman et al., 2013).
This further highlights the specificity and complexity inherent
in regulation of disuse atrophy and by extension the control of
myonuclear domain.
Regardless of the unknown mechanisms initiating myonuclear
loss, elimination of myonuclei by nuclear apoptosis remains a
rational idea to explain myonuclear domain size consistency in
the face of atrophy, reviewed by Siu and Alway (2009). Allen
et al. (1997a) published the first research demonstrating that
the myonuclei lost with atrophy (HS) were eliminated by “pro-
grammed nuclear death,” apoptosis. Myonuclear apoptosis has
been identified with muscle disuse/unloading/wasting and can
be measured with the terminal deoxynucleotidyl transferase-
mediated deoxyuridine triphosphate nick end-labeling (TUNEL)
or by DNA fragmentation in gel electrophoresis (Allen et al.,
1997a; Dupont-Versteegden et al., 1999, 2006; Smith et al., 2000;
Leeuwenburgh et al., 2005). For example, after 16 days of HS,
rat soleus muscle had reduced number of myonuclei and the
size of the myonuclei were increased after HS but the DNA con-
tent did not differ (Wang et al., 2006). However, recent advances
in techniques for measuring apoptosis, particularly the ability
to measure in vivo and to differentiate between nuclear loss
inside and outside the muscle cell have permitted more accurate
assessment of apoptosis in the muscle. In a number of recent pub-
lications, small increases in TUNEL+ nuclei have been reported
but the location of these nuclei was outside the sarcolemma and
thus they have been identified as stroma cells (Bruusgaard et al.,
2012; Suetta et al., 2012).
In light of the above discussion, the concept of muscle atro-
phy coinciding with loss of myonuclei to maintain myonuclear
domain size is not conclusive. Nutritional restriction has been
reported to reduce muscle fiber size but not myonuclear number
thus decreasing the myonuclear domain size (Winick and Noble,
1966; Pitts, 1986). Some studies have found no loss of myonu-
clei or myonuclear apoptosis with situations of atrophy (Wada
et al., 2002; Gundersen and Bruusgaard, 2008). As highlighted in
an excellent review on myonuclear domains and muscle atrophy
(Gundersen and Bruusgaard, 2008), a lot of the research findings
noting myonuclear loss are based on cross-sectional histological
assessment of myonuclei at a specific time point. Bruusgaard and
Gundersen (2008) conducted an elegant study measuring in vivo
time lapse of single fibers and found that after 4 weeks of den-
ervation there was a 50% decrease in size of muscle fiber and no
change in myonuclear number. Other studies using single fiber
analysis have also found no change in myonuclear number in
rodent muscle (Wada et al., 2002; Aravamudan et al., 2006).
The method used to measure myonuclei and myonuclear
domain size is also important to consider for careful interpreta-
tion. Cell culture techniques provide a means for easy myonuclear
analysis after intervention. However, the number of myonuclei
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available for analysis is high and the proportion ofmyonuclei for a
given volume of myotube is more prominent than in whole mus-
cle where the contractile protein content overwhelms the internal
content of the fiber. The timing of the myonuclear sampling
is also important when determining whether apoptosis actually
occurs and it is difficult to maintain myotubes in culture for
long periods. Myotubes in culture are also often not subjected to
contractile forces and the relevance to disuse atrophy might be
questioned, although this does not preclude the investigation of
atrophy induced by other methods.
Loading of muscle prior to the induction of atrophy may
also influence the acute responses, especially to unloading. Siu
et al. (2005) reported that in recently hypertrophied muscle (with
increase in myonuclei) myonuclei undergo apoptosis during dis-
use. Bruusgaard et al. (2010) investigated this further by inves-
tigating the concept of “muscle memory” by overloading EDL
muscle of mice and rats to stimulate hypertrophy. The EDL mus-
cle was then denervated to induce muscle atrophy. In contrast to
Siu et al.’s work, this model of overload led to myonuclear accre-
tion with hypertrophy, and the newmyonuclei persisted even with
atrophy after denervation (Bruusgaard et al., 2010). This mainte-
nance of myonuclei in the animals with overload and denervation
was not seen in the animals who underwent only denervation.
The authors suggest that previous hypertrophy bouts may protect
skeletal muscle against myonuclear loss with atrophy. This may
be of benefit for individuals who will undergo bouts of enforced
disuse such as that seen with immobilization and/or bed rest
following elective surgical procedures.
It is also important to highlight that the various experimental
models used to investigate disuse atrophy differ substantially and
hence have varying degrees of physiological application. Although
animal models may seem too different from human models, it
is of extreme importance for development in the area that both
human and animalmodels are included in the research, whilst still
keeping in mind that these choices may differ in the extent that
the intervention can be applied. The most typical models of dis-
use atrophy are: denervation or hindlimb suspension in rodents;
immobilization or bed rest in humans. Previously, the techniques
used for analysis included histology, immunohistochemistry, gene
expression and protein content, but in vivo assessment, single
fiber assessment, myonuclear assessment, myonuclear domain
size estimations were typically lacking in most studies. Further,
the timing of muscle or myotube sampling will influence the
response recorded. As discussed in this review, this is particu-
larly evident when assessing the SC count in humans after short
immobilization bouts, longer bed rest and/or longer disuse seen
with spinal cord injury (Brooks et al., 2010; Verdijk et al., 2012;
Snijders et al., 2014). The muscle chosen for analysis i.e., slow
twitch soleus muscle, or fast twitch EDL muscle, or mixed mus-
cle from humans, are key factors in unraveling the complex but
enticing role of myonuclei in skeletal muscle atrophic situations.
Recent human research has highlighted sex differences in skeletal
muscle response to immobilization (Yasuda et al., 2005) which
should also be taken into consideration. Finally, new methods
should be developed or taken up bymore researchers, for example
the 3-dimensional analysis of myonuclear domain size andmuscle
volume measurements.
A fundamental question related to myonuclei, myonuclear
domain and the response to atrophic situations is the involvement
of skeletal muscle stem cells (SCs) in the maintenance of muscle
mass, and the response to muscle loss.
SATELLITE CELLS
Myonuclei in skeletal muscle are post-mitotic and cannot repli-
cate. Therefore, any increase in myonuclear number such as
required for growth and repair is a result of SC fusion, although
also to a very minor extent other stem- or stem cell-like cells
(Boppart et al., 2013). The quantity of SCs differs between mus-
cles, fiber types, developmental stages and species. In general,
there are more SCs in type I fibers than type II fibers; the number
of SC number does not change from birth to adulthood despite
increases in fiber size (Verdijk et al., 2013). However, this is age,
species and muscle specific (Gibson and Schultz, 1982; Mackey
et al., 2009; Verdijk et al., 2013). SCs are responsive to various
environmental influences, including disuse.
SCs have distinctive morphological features, including large
nuclear-to-cytoplasmic ratio, few organelles, small nuclei and
condensed interphase chromatin clearly visible using electron
microscopy (Mauro, 1961). While the gold standard measure-
ment of SCs is with electron-microscopy, SCs can also be iden-
tified with light microscopy and immunohistochemical labeling
of factors expressed by the SCs (for further details on transcrip-
tion factors and other markers expressed by SCs see the recent
review by Yin et al., 2013).While SCs express these markers, label-
ing with some of these will also identify other cells. Where this
is the case, the marker should not be used alone to identify SCs
but rather in combination with another or several other known
markers that (i) label the SCs but not the alternate cell; (ii) label
the alternate cell but not the SCs; or (iii) label adjacent structures
such as the sarcolemma or basal lamina. The choices for labeling
with immunohistochemistry should be carefully considered, par-
ticularly when one is assessing SCs after an unusual intervention
such as disuse that may affect SCs and myonuclei substantially.
Under normal situations SCs remain quiescent (Bischoff,
1990). Upon activation in response to stimuli present during
injury or growth, SCs enter the cell cycle (Bischoff, 1990). When
activated, SCs proliferate and express myogenic regulatory fac-
tors (MRFs), MyoD and Myf5 (Yablonka-Reuveni and Rivera,
1994; Zammit et al., 2002). After proliferation, most cells main-
tain MyoD but downregulate Pax7 and commit to differentiation
via activation of myogenin. Other myoblasts maintain Pax7 but
down-regulate MyoD and withdraw from the cell cycle regain-
ing markers that characterize quiescence (Nagata et al., 2006; Day
et al., 2007). All SCs undergo a stage of co-expressing Pax7 and
MyoD before the decision to self-renew or differentiate is made.
SCs have the ability to undergo both asymmetric as well as sym-
metric divisions (Kuang et al., 2007) either producing identical
progeny or different progeny (Kuang et al., 2007).
Over recent years, a number of key publications have demon-
strated that SCs are not all the same (Zammit, 2008; Biressi and
Rando, 2010; Scharner and Zammit, 2011) and variations exist
even between SCs in the same muscle (Ono et al., 2012). It is
thought that the surrounding area (niche) of the SC plays a role
in the fate and adaptive responsiveness of the SC (Kuang et al.,
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2007). Therefore, the environment that influences muscle fibers
and myonuclei will also have an effect on SCs. The role of SCs
in skeletal muscle atrophy and recovery is less well characterized
than their role in growth and injury repair. However, any reduc-
tion in the ability of SCs to respond to injury and trauma during
atrophy or upon reloading will be a further detrimental episode
for the muscle (Chargé and Rudnicki, 2004).
Although this review is focused onmuscle atrophy, it is impor-
tant to highlight that recent research has questioned the absolute
requirement of SCs for muscle hypertrophy. Skeletal muscle can
respond to hypertrophy stimulation even in animals without
SCs. In adult Pax7-DTA mice, which have greater than 90% of
SCs removed, the muscle can respond to an overload stimu-
lus (McCarthy et al., 2011). These muscles without SC have a
blunted response to regeneration, but are still able to hypertro-
phy (McCarthy et al., 2011). A number of studies in animals
have reported skeletal muscle hypertrophy without SC activa-
tion or incorporation of myonuclei (Amthor et al., 2009; Blaauw
et al., 2009; Raffaello et al., 2010; Lee et al., 2012; Wang and
McPherron, 2012). These studies demonstrate that hypertro-
phy can occur independently of both SC proliferation as well
as myonuclear accretion. This highlights the ability of rodent
skeletal muscle to respond to overexpression induced hypertro-
phy (i.e., AKT overexpression—Blaauw et al., 2009), myostatin
knock-out induced hypertrophy (Amthor et al., 2009), hyper-
trophy with overexpression of JunB in cell culture (Raffaello
et al., 2010). Further, hypertrophy induced by myostatin inhibi-
tion in adult mice preceded incorporation of myonuclei (Wang
and McPherron, 2012). This is also reported in animals which
are transgenically modified to inhibit syndecan4 or Pax7, there is
a hypertrophy response to hypertrophy stimulated by myostatin
blockade, even without SC proliferation and fusion (Lee et al.,
2012).
SATELLITE CELLS AND DISUSE ATROPHY
Early studies indicated that atrophic conditions lead to increases
in the number of apoptotic myonuclei both inside and outside
myofibers (Allen et al., 1997a; Vescovo et al., 1998). However,
more recent studies indicate no change in myonuclear numbers
with atrophy, and loss of SCs with atrophy is not a consistent
finding. For example, in recent human studies of 14 days immo-
bilization (Snijders et al., 2014), 28 days bed rest (Brooks et al.,
2010) there appears to be no change in SC number, but Suetta
et al. (Suetta et al., 2013) report an increase in SCs after 14 days
immobilization. In contrast, in a recently published paper report-
ing SC numbers in states of severe disuse atrophy, spinal cord
injury, individuals had significantly lower SC numbers in both
type I and type II fibers (Verdijk et al., 2012). Thus, the sever-
ity of disuse induced atrophy and the duration of the condition
must be considered when interpreting the existing literature.
Whether or not some SCs are lost during atrophy, it is still
an open question how and why function (e.g., mitotic ability) of
remaining SCs are is altered during atrophy and if so, whether
their functionality is can be restored with reloading. In studies
investigating alterations in SC content and proliferative ability,
the age and growth stage of the animals is important. To inves-
tigate the role of SCs and the effect which atrophy has on their
function, using young animals whose growth has not stabilized
can shed light on factors not investigated in other models. For
example, the SC may be more responsive during growth and this
may alter their response to the atrophy-inducing intervention
(see Darr and Schultz, 1989). SC response to potential interven-
tions to reduce atrophy may also be different when comparing the
growing, the adult or aged animal, thus interpretation and appli-
cation should be done with care. Mechanical unloading appears
to reduce the number of SCs (Darr and Schultz, 1989; Mozdziak
et al., 1998; Matsuba et al., 2009). This may be due to apopto-
sis of SCs as well as myonuclei in situations of atrophy (Jejurikar
et al., 2002; Jejurikar and Kuzon, 2003; Ferreira et al., 2006).
Wang et al. (2006) investigated the mechanisms underlying the
SC response to HS, particularly the distribution of SCs and the
level of mechanical load applied to the muscle. Their results
suggest that the regulation of SCs is dependent on the mechan-
ical loading and the location of the SC along the muscle fiber.
Unloading resulted in a significant decrease in SC number, par-
ticularly at the central region of the muscle fibers (Wang et al.,
2006).
In contrast, Darr and Schultz (1989) showed that the alter-
ations in myonuclear and SC population were dependent on the
time course of HS. They investigated 30 days of HS in rat mus-
cle, particularly fast-twitch extensor digitorum longus (EDL) and
slow-twitch soleus muscle. After 3 days of HS, the authors report
a reduction in SC number and halting of mitotic activity in both
soleus and EDL muscle. Between 3 and 10 days of HS the SCs
began dividing and there was an increase throughout the remain-
der of the HS. In addition to the increase in dividing cells, the
EDL muscle also appeared to have a compensation response with
4x increase in active SCs in EDL myofibers. Although this study
found that the earlier response was reduced SC number and
mitotic activity, Ferreira et al. (2006) reported an intense peak
of proliferating activity in SCs after 6 h of HS (SC duplication)
followed by an increase in myonuclei at 12 h of HS (Ferreira
et al., 2006). During this time there also appeared to be apop-
tosis (Ferreira et al., 2006). Investigating the morphometric and
ultrastructural properties of SCs in rat soleus during immobi-
lization, Kujawa et al. (2005) found caveolae on the SCs and a
decrease in SC activity. Clearly, the SC response to atrophy is
biologically complicated. Interestingly, in a human study, when
specifically labeled with Pax7 and TUNEL+, there were no apop-
totically marked SCs after 14 days of immobilization (Suetta et al.,
2012).
In a seminal set of experiments,Mitchell and Pavlath examined
the properties of muscle precursor cells (MPCs include both SCs
and other stem-like cells between myofibers, fat and in blood ves-
sels) after 14 days of HS in mice (Mitchell and Pavlath, 2004) and
subsequent recovery. HS led to decreased number of MPCs and
these MPCs taken from atrophied muscle cells could not prolifer-
ate and differentiate in vitro into normal myonucleatedmyotubes.
Recovery appeared to lead to reversal of the dysfunctional proper-
ties highlighting that these changes are transient, lasting only until
normal weight bearing activities are resumed. This would seem
to imply that SC reactivation is integral to recovery. However, in
young animals Jackson et al. (2012) concluded that SCs are not
required for muscle growth following atrophy since restoration of
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myonuclear domain size with reloading after HS was independent
of SCs.
Mozdziak et al. (2001) investigated the interaction between
injury and HS, specifically the myofiber size, SC mitotic activ-
ity and DNA unit size after resumption of normal activities in
soleus muscles of rats. They found muscle injury combined with
inactivity (HS) caused long-term reduction in muscle size com-
pared with injury in weight bearing animals. After HS the SCs
responded to compensate for the muscle injury but this was not
enough to return myonuclear numbers to levels similar to that of
the animals who had not undergone HS (Mozdziak et al., 2001).
The authors speculated that the HS caused a disruption in “DNA
expression unit size” (such as seen in Mozdziak et al., 2000) and
combined with the reduction in SC mitotic activity results in a
reduced size of soleus muscle even after 9 weeks of reloading.
This interpretation indicates that the myonuclear domain size is
not necessarily primarily responsive to changes in muscle size, but
may itself have an active influence on muscle size.
Interestingly, while the number of SCs does not appear to
change in human muscle with short-term disuse (28 days or less),
it should be highlighted that alterations in MRFs have been docu-
mented. During 14 days of immobilization, Snijders et al. (2014)
report myogenin mRNA expression doubled. Further, after 28
days bed rest and essential AA supplementation without exer-
cise, MyoD transcripts were elevated after 28 days and remained
elevated after recovery (Brooks et al., 2010). Thus, SCs are not
quiescent when the environment is changing and there may be a
myogenic response occurring despite muscle proteolysis.
Investigations into treatments to reduce atrophic response
during HS have found that application of low-frequency electri-
cal stimulation (LFES) partially rescues the loss of SCs and lessens
the reduction in muscle cross-sectional area (Zhang et al., 2010);
rescues SCs and maintains their viability for muscle regeneration
(Guo et al., 2012) and reduces loss of myonuclear domain size
(Zhang et al., 2010). Zhang et al. (2010) applied LFES during HS
in a rat model and investigated SC response in soleus and EDL
muscles. The authors reported evidence of a reduced capacity for
SC activation, proliferation and differentiation in soleus muscle
after 28 days HS, findings that were partially attenuated by LFES.
Interestingly, there was no atrophy in the EDL muscle and no
alteration in myonuclear domain size in the EDL muscle (Zhang
et al., 2010).
In summary, the balance of data indicates that in animals SC
numbers decrease while in human studies SC numbers remain
similar or even increase unless the atrophic environment is par-
ticularly severe. Furthermore it seems the regenerative capacity,
and indeed the myogenic regulation of the remaining SC is main-
tained. Atrophy occurs under many conditions and unraveling
how SCs respond in the various conditions will need to include
better examination of the niche environments in which the SCs
reside and not only the quantitative responses. The response of
SCs to disuse atrophy is further complicated by the time course
of exposure to the condition and therefore research should be
including a broader timescale without sacrificing investigation of
the rapid early responses. Investigation of early responses should
include cell signaling events within SC and not only muscle tis-
sue itself. Extensive research has been done on the molecular
pathways which influence atrophy (see below) and some evidence
exists that SC are also influenced significantly by these pathways.
MOLECULAR SIGNALING PATHWAYS
The molecular mechanisms underpinning muscle atrophy with
disuse remain to be fully elucidated. The next section aims to
describe 3 of the key molecular pathways which are linked to
skeletal muscle atrophy: Atrogin-1/MAFbx and MuRF1; the IGF-
1-AKT-mTOR pathway; and the Myostatin Pathway. Existing
authoritative review articles will be highlighted. Further, we aim
to discuss how these pathways are related to SCs and myonuclear
responses to atrophy.
UBIQUITIN PROTEASOME PATHWAY (MAFbx/MuRF1) AND
DISUSE ATROPHY
The ATP-dependent ubiquitin proteasome pathway is the primary
degradation pathway of skeletal muscle in response to inactiv-
ity and disuse. The ubiquitin-proteasome pathway is involved
in breakdown of short-lived proteins or long-lived myofibril-
lar proteins in skeletal muscle. Three distinct components are
required for muscle breakdown using the ubiquitin proteasome
pathway. E1 ligases which activate ubiquitin, E2 ligases that are
responsible for transferring the activated ubiquitin to the pro-
tein molecule that is then targeted for degradation and the E3
ligases which regulate the actual transfer of ubiquitin to the pro-
tein. Two important skeletal muscle specific ubiquitin E3 ligases
are Muscle-specific RING Finger protein1 (MuRF1) and Muscle
Atrophy F-box (MAFbx/atrogin-1).
MAFbx and MuRF1 are both primarily expressed in skeletal
muscle and are upregulated in several models of disuse (Bodine
et al., 2001). MAFbx and MuRF1 were first identified following
profiling in mouse atrophy after fasting and immobilization in
a profound set of experiments published by both Bodine et al.
(2001) and Gomes et al. (2001). In knock-out models, animals
which cannot make MAFbx or MuRF1 proteins appear to be sim-
ilar to the wild-type animals with phenotypically similar muscle
and normal body weight (Bodine et al., 2001). However, MAFbx
knockout mice had a reduced loss of muscle mass (56% sparing)
after 7 and 14 days (Bodine et al., 2001). MuRF1 knockout mice
had a 36% sparing of muscle compared to wild-type mice 14 days
after denervation.
Both MAFbx and MuRF1 appear to be early markers of
disuse atrophy. MAFbx and MuRF1 mRNA levels are rapidly
increased in numerous models of atrophy and are thought to
contribute to the initiation of the atrophy process (Foletta et al.,
2011). They are increased after spaceflight in rodents (Allen
et al., 2009), after 3 days of ULLS in humans (Gustafsson
et al., 2010); and after immobilization (Jones et al., 2004; Abadi
et al., 2009). MAFbx and MuRF1 are regulated by the family of
Forkhead box O (FOXO) transcription factors (Stitt et al., 2004).
FOXO is a family of transcription factors that are involved in
metabolism, apoptosis and cell cycle progression (Carlsson and
Mahlapuu, 2002). When FOXO transcription factors are dephos-
phorylated they enter the nucleus and act to suppress growth
and promote apoptosis (Ramaswamy et al., 2002). AKT (also
called protein kinase B or PKB) phosphorylates FOXO transcrip-
tion factors on multiple sites leading to their exclusion from
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the nucleus. Under normal physiological conditions, AKT thus
inhibits the transcriptional functions of FOXO and FOXO is
unable to suppress growth or upregulate atrophy and myonuclei
are maintained.
IGF-1-PI3K-AKT-mTOR AND DISUSE ATROPHY
Extensive literature supports the role of the IGF-1-PI3K-AKT-
mTOR pathway in regulation of skeletal muscle hypertrophy
(for example see reviews Glass, 2003; Schiaffino et al., 2013).
Activation of this pathway leads to increases in translation
initiation factors ultimately leading to increased protein syn-
thesis: IGF1 activates Phosphatidylinositol 3 kinase (PI3K),
which phosphorylates phosphatidylinositol-4,5-bisphosphate to
phosphatidylinositol-3,4,5-trisphosphate in the membrane; this
creates a binding site for AKT; activation of AKT phosphorylates
and activates mammalian target of rapamycin (mTOR) kinase;
mTOR increases protein synthesis by phosphorylation and acti-
vation of p70S6kinase and eukaryotic translation initiation factor
4E binding protein 1, both of which are involved in translation
and protein synthesis. The activation of AKT appears to be a cru-
cial determinant of the cellular signaling processes and appears
to sit at the transition point between atrophy and hypertrophy
(again, see Glass, 2003; Schiaffino et al., 2013 for review).
With situations of disuse, AKT is not activated and this
contributes to muscle atrophy via FOXO (Sandri et al., 2004).
Animals with overexpression of FOXO have reduced muscle mass
and this appears to be related to increases in MAFbx and MuRF1
(see above). Increased FOXO transcript levels in rodents were
reported after spaceflight (Allen et al., 2009) and decreased phos-
phorylation of AKT levels were reported after 10 days HS (Sugiura
et al., 2005). Alterations in the IGF1-AKT-mTOR pathway are
linked directly to alterations in the ubiquitin proteasome ligases,
MAFbx and MuRF1 (Kandarian and Jackman, 2006). Activation
of the IGF-1 pathway is significant in reducing FOXO transloca-
tion. Inhibition of the IGF-1 pathway caused FOXO translocation
to the nucleus, promoted growth suppression and stimulated
proteolysis (Stitt et al., 2004). In humans, after 5 days of immo-
bilization without intervention, transcript levels of MAFbx and
MuRF1 were increased (Dirks et al., 2014). However, no increases
in FOXO were noted after 4 or 14 days of immobilization (Suetta
et al., 2012).
Relocation of FOXO to the nucleus also activates genes
involved in cell death and cell cycle inhibition (Stitt et al., 2004)
and may therefore potentially affect SC proliferation. IGF-1 is
known to act directly on SCs. IGF-1 leads to SC proliferation
and its absence is associated with lower proliferation capacity.
Therefore, interventions that focus on the IGF-1/mTOR path-
way will also induce activation of the support-system for addition
of myonuclei. IGF-1 acts both intracellularly and extracellularly
to induce both proliferation and differentiation of SCs (Bischoff,
1986; Adams and Haddad, 1996; Adams, 1998; Cameron-Smith,
2002; Mourkioti and Rosenthal, 2005) and different isoforms of
IGF-1may be responsible for these (see Review for further reading
of the IGF-1 and skeletal muscle regeneration and hypertrophy:
Philippou et al., 2007). mTOR has been described as the master
regulator of cellular processes and has been linked to differenti-
ation in C2C12 myobalsts (Erbay et al., 2003; Han et al., 2008).
While its role in myogenic differentiation has not been conclu-
sively clarified, mTOR is thought to play a role in regulating
MyoD stability (Sun et al., 2010). Further clarification of the inter-
action of mTOR, as well as other key components of the pathway,
with SC function remain to be elucidated.
MYOSTATIN AND DISUSE ATROPHY
Myostatin (growth-differentiation factor 8, GDF8) is a member
of the transforming growth factor (TGF)β superfamily and a
negative regulator of muscle mass. Myostatin appears to be pri-
marily found in muscle tissue (McPherron et al., 1997). It has
been widely reported that either natural mutations or scientific
knock-out animals without myostatin gene have hypertrophied
muscles such as the “double muscled” cattle (Grobet et al., 1997;
Kambadur et al., 1997; McPherron and Lee, 1997) and the sig-
nificant hypertrophy in a child (Schuelke et al., 2004). Myostatin
knockout mice were larger in size than wild-type littermates
and had over 200% greater muscle mass (McPherron et al.,
1997). When myostatin gene expression is blocked experimen-
tally, there are 13–30% increases in skeletal muscle hypertrophy
(Whittemore et al., 2003).
The relationship between myostatin and atrophy is less con-
crete. Overexpression of myostatin appears to lead to muscle
atrophy in transgenic mice (Reisz-Porszasz et al., 2003). Increased
levels of myostatin mRNA and protein levels are seen as early as
1 day after HS (Carlson et al., 1999), after sciatic nerve resection
(Shao et al., 2007) and after 11 days of spaceflight in mice (Allen
et al., 2009) and in humans after chronic disuse (Reardon et al.,
2001). Serum myostatin levels were increased by 12% after 25
days of head down bed rest (Zachwieja et al., 1999) while myo-
statin transcript and protein levels were both increased after 3
days of ULLS (Gustafsson et al., 2010). Increased myostatin tran-
script levels have been report after 5 days (Dirks et al., 2014) while
after 14 days of immobilization the same group report decreased
protein levels of myostatin (Snijders et al., 2014).
Myostatin appears to inhibit muscle growth through inhibiting
the AKT-mTOR pathway (less protein synthesis), upregulating
the ubiquitin proteasomal pathway via FOXO (more protein
breakdown) (McFarlane et al., 2006) and reducing SC differen-
tiation (Langley et al., 2002; Zimmers et al., 2002). Myostatin
activates withdrawal from the cell cycle in mammalian myoblasts
and stimulates quiescence rather than differentiation or apopto-
sis (McFarlane et al., 2008) by inhibiting MyoD activity (Langley
et al., 2002;McCroskery et al., 2003; Amthor et al., 2006;Manceau
et al., 2008).
Promoting quiescence is not the only influence that myostatin
has on SCs. It also seems to play a role in regulating SC self-
renewal in cell culture (McFarlane et al., 2008). Excess myostatin
inhibited Pax-7 expression, whereas inactivation of myostatin
(by genetic inactivation or functional antagonism of myostatin)
resulted in increased Pax7 expression (McFarlane et al., 2008).
Increased myostatin protein levels have been linked with dysfunc-
tional SCs in aging humanmuscle (McKay et al., 2012). While the
intricate response of skeletal muscle to ageing is outside the scope
of this review, this evidence suggests that increased myostatin lev-
els seen with atrophy may contribute to the reduced proliferative
ability of SCs and the reduction in the pool of parent SCs.
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Myostatin activates the SMAD pathway and SMAD3 null mice
had significant atrophy combined with increased levels of MuRF1
and decreased SC function (Ge et al., 2011). This response was
initiated by increased myostatin levels in the SMAD3 null mice,
and the response was abolished when myostatin was inactivated
in these mice (Ge et al., 2011). SMAD3 may contribute to self-
renewal of SCs. Myostatin also acts via other SMAD pathways and
cell signaling downstream of myostatin interacts with the IGF-1
pathway.
Follistatin is a natural inhibitor of myostatin. Animals with
overexpression of follistatin have increased muscle mass (Lee and
McPherron, 2001; Haidet et al., 2008), and the muscles are larger
than withmyostatin knock-out alone (Lee, 2007). Overexpression
of follistatin appears to result in increased SC activation as well
as increased protein synthesis (Gilson et al., 2009). In this study,
increased fiber size was accompanied by increases in myonuclear
number (Gilson et al., 2009). The further study of the role of fol-
listatin as a therapeutic aid inmaintenance of muscle mass despite
atrophy-stimulating conditions is certainly warranted.
SCs have the ability to differentiate across lineages including
adipogenic and myogenic lineages. In situations of disuse, there
are increased levels of intramuscular adipose tissue (IMAT). The
increase in adipose may be due to the reduction of regenerative
capacity of SCs (Chargé and Rudnicki, 2004) which may con-
tribute to an abnormal shift toward the adipogenic lineage such
as that seen in ageing skeletal muscle (Kirkland et al., 2002).
SCs from obese animals produce myotubes that have impaired
insulin sensitivity. In SCs cultured from obese animals there is
an increased number progressing to the adipogenic lineage rather
than the myogenic lineage which suggests that metabolic condi-
tions lead to an increased proportion of SCs entering the adi-
pogenic pathway which may contribute to the greater fat deposit
in skeletal muscle (Scarda et al., 2010). It is thought that myo-
statin may be one of the key regulators of SCs and may play a role
in determining the fate of SCs to adipogenic lineage or myogenic
lineage (Deng et al., 2012).
In summary, despite atrophy occurring in the multinucleated
muscle fibers, SCs are also influenced by the molecular path-
ways activated during the atrophy process. The alterations in
both number and mitotic ability of SCs with atrophy are medi-
ated, at least in part through increased myostatin. The influence
of myostatin (and follistatin) on the potential of both SCs and
pluripotent stem cells to differentiate into different lineages, is
of extreme significance for skeletal muscle health as well as for
prospects of clinical medicine and therapies aimed at maintaining
and positively influencing skeletal muscle.
RESTORATION OF SKELETAL MUSCLE AFTER DISUSE
ATROPHY
Reapplying mechanical load appears to be the most effective
method to restoremusclemass, and increasemyonuclear number,
SC number and regenerative capacity.
Resistance exercise increasesmusclemass and by increasing the
load placed on the muscle which activates the PI3-AKT-mTOR
pathway and increases protein synthesis. As little as one bout of
resistance exercise in healthy individuals has been reported to
increase IGF1 gene expression (Chesley et al., 1992). In young
individuals, resistance exercise leads to increased protein synthe-
sis after 2–4 h (Phillips et al., 1997) and this increase is maintained
for 24–48 h in untrained individuals (Phillips et al., 1997).
In models of disuse, such as bed rest and immobilization,
resistance exercise alone has been reported to reduce, but not
completely alleviate muscle loss. Resistance exercise during 14
days of single leg immobilization in humans was sufficient to
preserve quadriceps muscle mass (Oates et al., 2010) and dur-
ing bed rest exercise alone reduces loss in muscle mass (Ferrando
et al., 1997). As mentioned earlier, SCs appear to be activated
and used with increases in mass from resistance exercise. In an
interesting model to attempt to alleviate muscle loss with immo-
bilization, during 5 days of HS, animals undertook resistance
exercise with one leg (a combination of concentric, eccentric
and isometric contractions) and the other leg remained as con-
trol. The leg which exercised during the HS maintained muscle
mass and myofibril content (Adams et al., 2007). The stimu-
lus was sufficient to increase gene expression of IGF1, myogenin
and decrease myostatin. Further, increased p70S6K was reported.
Thus, combination resistance exercise was sufficient to counter
the initial alterations of disuse-induced muscle atrophy in mice
(Adams et al., 2007).
Another form of atrophy prevention is electrical stimulation
and stretching. However, these interventions did not reduce atro-
phy after 7 days following denervation in rats (Russo et al., 2010).
This intervention reduced gene expression of MyoD, MAFbx,
and MuRF1 levels whilst Myostatin gene expression was main-
tained, but there was no reduction in atrophy (Russo et al.,
2010). Neuromuscular electrical stimulation has shown promis-
ing results in 5 days of immobilization in humans (Dirks et al.,
2014). Applying electrical stimulation during 5 days of immo-
bilization prevented the muscle loss and prevented the increase
in myostatin, MAFbx and MuRF1 transcript levels (Dirks et al.,
2014).
Protein synthesis and degradation are influenced by nutrient
intake and intake of proteins and amino acids stimulate muscle
protein synthesis and inhibits protein breakdown (Rennie et al.,
1982). In particular, leucine, an essential amino acid, is a power-
ful stimulator of protein synthesis. Carbohydrate and protein are
known to stimulate protein synthesis and can positively influence
IGF1-mTOR-AKT pathway to stimulate protein synthesis and
prevent upregulation of FOXO, MuRF1, and MAFbx; therefore
nutritional intake could be a countermeasure in reducing mus-
cle mass loss with disuse, particularly in situations where exercise
is not feasible (such as hospitalized bed rest). Essential AA have
consistently been shown to influence protein synthesis and allevi-
ate some, but not all, of the loss of skeletal muscle experienced
with bed rest (Paddon-Jones et al., 2004) but not to the same
extent as exercise. However, with immobilization, amino acid
supplementation does not appear to reduce loss of muscle mass
(Stein and Blanc, 2011). An “anabolic resistance” was observed
in healthy young individuals after immobilization (Glover et al.,
2008) where there was decrease in muscle size and protein syn-
thesis was 68% greater in the non-immobilized leg compared to
the immobilized leg. There was also a reduced phosphorylation
of AKT and p70S6K (Glover et al., 2008). Amino acid sup-
plementation with immobilization improved protein synthesis
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but did not completely alleviate alterations with immobilization
(Glover et al., 2008). Twenty-eight days of immobilization with
protein and amino acid supplementation (28 g protein) did not
prevent increases in myostatin, MuRF1 or MAFbx compared with
immobilization alone (Bunn et al., 2011). In addition, after 14
days of immobilization there was a 31% decrease in post-prandial
protein synthesis rate after consuming 20 g protein (Wall et al.,
2013) demonstrating that the concept of anabolic resistance to
protein ingestion occurs prior to 28 days. Studies assessing the
influence of amino acid supplementation on SC and myonuclear
response are an essential part of the keys to understanding the role
of SCs and influence of exercise and nutrition.
Amino acid supplementation alone does not appear to reduce
muscle atrophy, however combined with resistance exercise they
provide an effective countermeasure. Some, but not complete,
preservation of muscle mass and strength was reported after 28
days of bed rest with resistance exercise combined with amino
acid supplementation (Brooks et al., 2008). Interestingly, the
myogenic response was more pronounced in those who did not
exercise during bed rest (receiving only the AA supplement) who
had greater atrophy than those who exercised (Brooks et al.,
2010). Myostatin transcript levels were increased significantly in
the group who did not exercise compared with those who did.
There was no difference in SC numbers after 28 days of bed rest or
recovery indicating that the stimulus was not sufficient to increase
and sustain SCs (Brooks et al., 2010). One can speculate that grav-
ity combined with resistance exercise is needed to stimulate SC
response.
Overexpression of IGF-1 did not protect mice against mus-
cle loss with cast immobilization. After 1 week of reambula-
tion after immobilization, mice with IGF-1 overexpression had
enhanced muscle regeneration including increased muscle size,
central myonuclei and Pax7+ cells (Stevens-Lapsley et al., 2010).
During rehabilitation exercise after disuse in humans, myo-
statin levels were supressed and sustained at lower levels through-
out rehabilitation (Jones et al., 2004; Hittel et al., 2010). The
reduced myostatin levels during rehabilitation exercise may act,
at least in part, by releasing the inhibition on SCs and promoting
muscle recovery via SCs (as discussed earlier) as well as increased
AKT levels and activity (Morissette et al., 2009; Trendelenburg
et al., 2009). These interventions are key to recovery from disuse
atrophy and rehabilitation to functional status.
An excellent natural model to study resistance to atrophy is
hibernation. Small mammals undergo long periods of reduced
activity and hypocaloric intake. Hibernating animals are pro-
tected against muscle loss—despite inactivity and anorexia (for
review, see Storey and Storey, 2007). Compared to the response
of non-hibernating animals, such as humans and rodents, hiber-
nating animals appear to be resistant to atrophy with disuse
(Rourke et al., 2004a,b). Larger hibernating animals also appear
to avoid protein loss and maintain functional capacity of skele-
tal muscle (Harlow et al., 2001; Lohuis et al., 2007). Hibernating
animals have elevated MAFbx levels but this is not associated
with atrophy (Rourke et al., 2004b). Myostatin protein levels are
not increased during early hibernation and torpor, but increase
during early arousal prior to resuming normal body temperature
(Brooks et al., 2011).
In general, mammals lack the ability to prevent significant
atrophy with disuse or disease. Hibernating grounds squirrels
provide a natural model to studymechanism of resistance to atro-
phy in conditions of disuse and hypocaloric intake. The response
of SCs and myonuclei could prove to be extremely insightful as
to the natural response of muscle to resisting atrophy. By under-
standing the natural response to maintain myonuclear and SC
function as well as with muscle atrophy will provide insight into
the factors influencing atrophy and reduced function with disuse,
normally an atrophy-inducing state.
SUMMARY
Since their first discovery in the 1960s, SCs have rightly played a
prominent role in skeletal muscle research. Both SCs and myonu-
clei respond to the environmental changes which occur with
disuse atrophy. The full role which they play to establish a new
homeostatic environment for the muscle fiber, and/or the sur-
rounding niche area, and the influence that the environment has
on them, remains to be elucidated. The alterations in skeletal
muscle with disuse atrophy such as myostatin and IGF1-AKT-
mTOR appear to influence SCs as well as muscle mass. Despite
no change in SC numbers with short duration human studies
(<30 days), the SCs are not quiescent when their environment
is changing but rather they are responding to the alterations in
the niche area. This review brings together the current knowledge
of myonuclear and SC response to disuse atrophy and highlights
the complexity of the response in animals and humans.
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